Laboratorios Salvat, S.A.
Records under this name other than the patents Laboratorios Salvat, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Back to Laboratorios Salvat, S.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,040,701 | Apaf-1 inhibitor compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,524,894 | Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 Lapsed on the fee record Ended Sep 3, 2025 · USPTO record | Lapsed on the fee record | Ended Sep 3, 2025 | USPTO record |
| US 8,822,452 | Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 Lapsed on the fee record Ended Sep 2, 2022 · USPTO record | Lapsed on the fee record | Ended Sep 2, 2022 | USPTO record |
| US 8,871,787 | Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester Lapsed on the fee record Ended Oct 28, 2018 · USPTO record | Lapsed on the fee record | Ended Oct 28, 2018 | USPTO record |
| US 7,115,629 | Carbamates derived from arylalkylamines Lapsed on the fee record Ended Oct 3, 2018 · USPTO record | Lapsed on the fee record | Ended Oct 3, 2018 | USPTO record |
| US 8,492,402 | Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester Lapsed on the fee record Ended Jul 23, 2017 · USPTO record | Lapsed on the fee record | Ended Jul 23, 2017 | USPTO record |
| US 6,916,828 | Carbamates derivatived from arylakylamines Lapsed on the fee record Ended Jul 12, 2017 · USPTO record | Lapsed on the fee record | Ended Jul 12, 2017 | USPTO record |
| US 7,452,904 | 1-Alkyl-1-Azoniabicyclo' 2.2.2 Octane Carbamate Derivatives and Their Use as Muscarinic Receptor Antagonists Formerly held Lapsed on the fee record Ended Nov 18, 2016 · High confidence | Lapsed on the fee record | Ended Nov 18, 2016 | High confidence |
| US 7,423,172 | Tyrosine derivatives as PPAR-γ-modulators Lapsed on the fee record Ended Sep 9, 2012 · USPTO record | Lapsed on the fee record | Ended Sep 9, 2012 | USPTO record |
| US 6,670,365 | Substituted imidazo 1,2a}azines as selective inhibitors of cox-2 Lapsed on the fee record Ended Dec 30, 2007 · USPTO record | Lapsed on the fee record | Ended Dec 30, 2007 | USPTO record |